102 related articles for article (PubMed ID: 1754730)
1. Effect of verapamil on the uptake and efflux of etoposide (VP16) in both sensitive and resistant cancer cells.
Feng MR; Liebert M; Wedemeyer G; Grossman HB; Mancini WR; Williams M; Wagner JG
Sel Cancer Ther; 1991; 7(2):75-83. PubMed ID: 1754730
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of multiple drug resistance in human bladder cancer cell lines.
Shinohara N; Liebert M; Wedemeyer G; Chang JH; Grossman HB
J Urol; 1993 Aug; 150(2 Pt 1):505-9. PubMed ID: 8100862
[TBL] [Abstract][Full Text] [Related]
3. The uptake and efflux of doxorubicin by a sensitive human bladder cancer cell line and its doxorubicin-resistant subline.
Usansky JI; Liebert M; Wedemeyer G; Grossman HB; Wagner JG
Sel Cancer Ther; 1991; 7(4):139-50. PubMed ID: 1822001
[TBL] [Abstract][Full Text] [Related]
4. Verapamil-induced augmentation of etoposide accumulation in L1210 cells in vitro.
Yalowich JC; Ross WE
Cancer Res; 1985 Apr; 45(4):1651-6. PubMed ID: 3978633
[TBL] [Abstract][Full Text] [Related]
5. Characterisation of multidrug-resistant Ehrlich ascites tumour cells selected in vivo for resistance to etoposide.
Nielsen D; Maare C; Eriksen J; Litman T; Friche E; Skovsgaard T
Biochem Pharmacol; 2000 Aug; 60(3):353-61. PubMed ID: 10856430
[TBL] [Abstract][Full Text] [Related]
6. Establishment and characterization of resistant cells to etoposide (VP16) from a mouse breast cancer cell line, FM3A.
Takagi E; Kawatsu H; Shimokata K; Nishiyama Y; Kojima K; Yoshida S
Jpn J Cancer Res; 1988 Aug; 79(8):938-44. PubMed ID: 2846485
[TBL] [Abstract][Full Text] [Related]
7. Induction of drug-resistant bladder carcinoma cells in vitro: impact on polychemotherapy with cisplatin, methotrexate and vinblastine (CMV).
Rohde D; Brehmer B; Kapp T; Valdor M; Jakse G
Urol Res; 1998; 26(4):249-57. PubMed ID: 9759998
[TBL] [Abstract][Full Text] [Related]
8. Establishment and characterization of doxorubicin-resistant human bladder cancer cell line, KK47/ADM.
Kimiya K; Naito S; Soejima T; Sakamoto N; Kotoh S; Kumazawa J; Tsuruo T
J Urol; 1992 Aug; 148(2 Pt 1):441-5. PubMed ID: 1353119
[TBL] [Abstract][Full Text] [Related]
9. Concentration- and time-dependent cytostatic effects of methotrexate and etoposide on L1210 leukemic cells in vitro demonstrated by a new microperfusion method.
Gimmel S; Maurer HR
Anticancer Res; 1994; 14(1A):129-35. PubMed ID: 8166439
[TBL] [Abstract][Full Text] [Related]
10. Role of differential drug uptake, efflux, and binding of etoposide in sensitive and resistant human tumor cell lines: implications for the mechanisms of drug resistance.
Politi PM; Sinha BK
Mol Pharmacol; 1989 Mar; 35(3):271-8. PubMed ID: 2564628
[TBL] [Abstract][Full Text] [Related]
11. [The activity of etoposide (VP16) in combination chemotherapy against human bladder cancer cells in vitro].
Hattori T; Satoh M; Terashima Y; Nishimura T; Akimoto M
Hinyokika Kiyo; 1991 Sep; 37(9):995-8. PubMed ID: 1785427
[TBL] [Abstract][Full Text] [Related]
12. Verapamil potentiation of VP-16-213 in acute lymphatic leukemia and reversal of pleiotropic drug resistance.
Slater LM; Murray SL; Wetzel MW; Sweet P; Stupecky M
Cancer Chemother Pharmacol; 1986; 16(1):50-4. PubMed ID: 3455667
[TBL] [Abstract][Full Text] [Related]
13. Trifluoperazine modulation of resistance to the topoisomerase II inhibitor etoposide in doxorubicin resistant L1210 murine leukemia cells.
Kamath N; Grabowski D; Ford J; Drake F; Kerrigan D; Pommier Y; Ganapathi R
Cancer Commun; 1991 Feb; 3(2):37-44. PubMed ID: 1995027
[TBL] [Abstract][Full Text] [Related]
14. Potentiation of etoposide-induced DNA damage by calcium antagonists in L1210 cells in vitro.
Yalowich JC; Ross WE
Cancer Res; 1984 Aug; 44(8):3360-5. PubMed ID: 6744270
[TBL] [Abstract][Full Text] [Related]
15. Circumvention of drug resistance in human non-small cell lung cancer in vitro by verapamil.
Merry S; Courtney ER; Fetherston CA; Kaye SB; Freshney RI
Br J Cancer; 1987 Oct; 56(4):401-5. PubMed ID: 2825748
[TBL] [Abstract][Full Text] [Related]
16. Increased phosphorylation of DNA topoisomerase II in etoposide-resistant mutants of human cancer KB cells.
Takano H; Kohno K; Ono M; Uchida Y; Kuwano M
Cancer Res; 1991 Aug; 51(15):3951-7. PubMed ID: 1649696
[TBL] [Abstract][Full Text] [Related]
17. Time-lapse live cell imaging and flow analysis of multidrug resistance reversal by verapamil in bladder cancer cell lines.
Featherstone JM; Lwaleed BA; Speers AG; Hayes MC; Birch BR; Cooper AJ
Urology; 2009 Aug; 74(2):378-84. PubMed ID: 19501884
[TBL] [Abstract][Full Text] [Related]
18. P-glycoprotein-independent mechanism of resistance to VP-16 in multidrug-resistant tumor cell lines: pharmacokinetic and photoaffinity labeling studies.
Politi PM; Arnold ST; Felsted RL; Sinha BK
Mol Pharmacol; 1990 Jun; 37(6):790-6. PubMed ID: 1972771
[TBL] [Abstract][Full Text] [Related]
19. Verapamil enhanced in vitro chemosensitivity of a murine bladder carcinoma, FCB.
Ballou RJ; Simpson WG; Harty JI; Tseng MT
Urol Res; 1986; 14(4):195-200. PubMed ID: 3097900
[TBL] [Abstract][Full Text] [Related]
20. UM-UC-1 and UM-UC-2: characterization of two new human transitional cell carcinoma lines.
Grossman HB; Wedemeyer G; Ren L
J Urol; 1984 Oct; 132(4):834-7. PubMed ID: 6471236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
